Drugs / X-ACT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02327390 | Mar 2015 → Jul 2016 | cutaneous melanoma | Case Comprehensive Cancer Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | X-ACT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02327390 ↗ |
| Modality | Cell therapy | “The activated T cells are then injected back into the same participant using an i.v.” NCT02327390 ↗ |
| Route | Intravenous | “Administered as an IV infusion” NCT02327390 ↗ |